Advertisement

Experientia

, Volume 41, Issue 7, pp 930–931 | Cite as

Inhibition of virus multiplication and alteration of cyclic AMP level in cell cultures by flavonoids

  • I. Mucsi
  • B. M. Prágai
Short Communications Biochemistry and Biophysics, Metabolism, Neurobiology, Pharmacology

Summary

The inhibitory effect of four flavonoid compounds on virus multiplication and their influence on the intracellular cyclic AMP (cAMP) level were studied in cell cultures. Quercetin and quercitrin reduced the yields ofHuman (alpha) herpesvirus 1 (HSV-1) andSuid (alpha) herpesvirus 1 (pseudorabies virus), but hesperidin and rutin had no effect. Further, quercetin and quercitrin elevated the intracellular level of cAMP, whereas hesperidin and rutin did not alter the cAMP level. Both antiviral activity and cAMP-enhancing effect were dependent on the concentrations of the flavonoids, and these effects turned out to be parallel.

This study suggests that a relation exists between the antiviral effect and the cAMP-enhancing activity of flavonoids.

Key words

flavonoids cyclic AMP-enhancing activity human (alpha) herpesvirusSuid (alpha) herpesvirus

References

  1. 1.
    Acknowledgment. We wish to thank Prof. Dr I. Béládi for helpful discussions and advice.Google Scholar
  2. 2.
    Havsteen, B., Biochem. Pharmac.32 (1983) 1141.Google Scholar
  3. 3.
    Cutting, W.C., Dreisbach, R.H., and Neff, B.J., Stanford med. Bull.7 (1949) 137.Google Scholar
  4. 4.
    Cutting, W.C., Dreisbach, R.H., and Matsushima, F., Stanford med. Bull.11 (1953) 227.PubMedGoogle Scholar
  5. 5.
    Bakay, M., Mucsi, I., Béládi, I., and Gábor, M., Acta microbiol. Acad. Sci. hung.15 (1968) 223.PubMedGoogle Scholar
  6. 6.
    Béládi, I., Pusztai, R., Mucsi, I., Bakay, M., and Gábor, M., Ann. N.Y. Acad. Sci.284 (1977) 358.PubMedGoogle Scholar
  7. 7.
    Veckenstedt, A., Béládi, I., and Mucsi, I., Arch. Virol.57 (1978) 255.PubMedGoogle Scholar
  8. 8.
    Graziani, Y., and Chayoth, R., Biochem. Pharmac.26 (1977) 1259.Google Scholar
  9. 9.
    Beretz, A., Anton, R., and Stoclet, J.C., Experientia34 (1978) 1054.PubMedGoogle Scholar
  10. 10.
    Ferrel, J.E. Jr, Chang Sing, P.B.G., Loew, G., King, R., Mansour, J.M., and Mansour, T., Molec. Pharmac.16 (1979) 556.Google Scholar
  11. 11.
    Stanwick, T.L., Anderson, R.W., and Nahmias, A.J., Infect. Immun.18 (1977) 342.PubMedGoogle Scholar
  12. 12.
    Maassab, H.F., and Soltysiak, R.M., Ann. N.Y. Acad. Sci.284 (1977) 375.PubMedGoogle Scholar
  13. 13.
    Stanwick, T.L., and Nahmias, A.J., Arch. Virol.72 (1982) 247.PubMedGoogle Scholar
  14. 14.
    Macpherson, I., and Stoker, M., Virology16 (1962) 147.Google Scholar
  15. 15.
    Reed, L.J., and Muench, H.A., Am. J. Hyg.27 (1938) 493.Google Scholar
  16. 16.
    Cserey-Pechány, É., Béládi, I., and Ivánovics, G., Acta physiol. hung.2 (1951) 229.PubMedGoogle Scholar
  17. 17.
    Degré, M., and Rollag, M., J. Interferon Res.2 (1982) 151.PubMedGoogle Scholar
  18. 18.
    Ishitsuka, H., Ohsawa, C., Ohiwa, T., Umeda, I., and Suhara, Y., Antimicrob. Ag. Chemother.22 (1982) 611.Google Scholar
  19. 19.
    Biron, K.K., and Raska, K. Jr, Virology56 (1973) 383.PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1985

Authors and Affiliations

  • I. Mucsi
    • 1
  • B. M. Prágai
    • 1
  1. 1.Institute for MicrobiologyUniversity Medical SchoolSzeged(Hungary)

Personalised recommendations